A study published in the British Journal of Pharmacology on 3 March, led by University of Queensland researchers Associate Professor Trent Woodruff and Dr John Lee, has found the drug “PMX205” extends the life of mice that have a SOD1 mutation, when administered before or during very early disease onset. More studies are now underway to determine the safety of PMX205 before it can be tested in humans. 'Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis' tttp://onlinelibrary.wiley.com/doi/10.1111/bph.13730/full
Postive results for PMX205 in mice with SOD1 mutation
Latest News
A pivotal step forward for the MND community in NSW - MND becomes a notifiable disease
MND NSW welcomes the NSW Government’s announcement that motor neurone disease (MND) will become a notifiable condition, marking a significant mileston...
Thank You to our Supporters
As we approach the end of the financial year, I want to take a moment to personally thank you—our donors, fundraisers, walkers, and supporters—fo...
Wellington Correctional Centre Staff Rally for MND NSW
We'd like to sincerely thank the staff at Wellington Correctional Centre who recently held an MND Ice Bucket Challenge in support of families facing M...
Julie-Ann and Jayne's MND Story
Jayne Christian is a carer for her mum, Julie-Ann Christian, who is living with MND and has shared their story. Jayne is currently Artist in Residence...